000 | 01065 a2200277 4500 | ||
---|---|---|---|
005 | 20250517162810.0 | ||
264 | 0 | _c20180329 | |
008 | 201803s 0 0 eng d | ||
022 | _a2159-8290 | ||
024 | 7 |
_a10.1158/2159-8290.CD-17-0481 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSinha, Seema | |
245 | 0 | 0 |
_aThe Path of Most Resistance: Transdifferentiation Underlies Exceptional Nonresponses to Androgen Receptor Pathway Inhibition in Prostate Cancer. _h[electronic resource] |
260 |
_bCancer discovery _c07 2017 |
||
300 |
_a673-674 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 |
_aCell Transdifferentiation _xdrug effects |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aReceptors, Androgen _xdrug effects |
700 | 1 | _aNelson, Peter S | |
773 | 0 |
_tCancer discovery _gvol. 7 _gno. 7 _gp. 673-674 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/2159-8290.CD-17-0481 _zAvailable from publisher's website |
999 |
_c27345057 _d27345057 |